Sign up to save your podcasts
Or
Share July Medtech Recap: Q2 Earnings, Deals, and Robotic Endoscopy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
July Medtech Recap: Q2 Earnings, Deals, and Robotic Endoscopy
Strong earnings, mega-deals, and a robotics shake-up highlight medtech’s Q2. Nicholas Talamantes joins to cover the numbers, the moves, and the strategies setting the tone for the second half of the year.
Episode Breakdown:
00:00 – Opening and show introduction
01:02 – Meet guest Nicholas Talamantes and episode agenda
02:02 – Q2 earnings overview and market growth
05:15 – Spin-outs, mega-deals, and the venture ecosystem
08:39 – Key takeaways from a strong Q2
09:01 – Trade policy, tariffs, and AI regulation
14:25 – Trending stories: cardiology leads funding
16:57 – Acquisitions and diagnostics momentum
19:12 – Chronic disease management and IVD growth
22:01 – Strategic divestitures across medtech
24:44 – Robotics market snapshot and trends
28:52 – Olympus and Revival: robotic endoscopy push
31:21 – Fractal Health and Aqua Medical innovations
33:59 – Think Surgical and platform competition
35:28 – Biggest deals and raises in Q2
37:32 – Zimmer Biomet to acquire Monogram
41:56 – Favorite deals: Cardamon PFA and Nēros Medical
44:36 – Wrap-up and medtech resilience
45:14 – Compass platform and Europe plans
46:50 – Closing thanks and subscribe
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Subscribe to our LinkedIn Newsletter
https://www.stateofmedtechpodcast.com/
Follow The State of MedTech on
LinkedIn https://www.linkedin.com/company/thestateofmedtech
Instagram https://www.instagram.com/stateofmedtech/
TikTok https://www.tiktok.com/@stateofmedtech
X https://twitter.com/StateofMedTech
Facebook https://www.facebook.com/stateofmedtech/
Follow Omar M. Khateeb on
LinkedIn https://www.linkedin.com/in/okhateeb/
Instagram https://www.instagram.com/omar.m.khateeb/
TikTok https://www.tiktok.com/@omarkhateebofficial
X https://twitter.com/OmarMKhateeb
Facebook https://www.facebook.com/OmarMKhateeb/
#Medtech #HealthcareBusiness #EarningsSeason #MedicalDevices #Robotics
View all episodes
By State of MedtechStrong earnings, mega-deals, and a robotics shake-up highlight medtech’s Q2. Nicholas Talamantes joins to cover the numbers, the moves, and the strategies setting the tone for the second half of the year.
Episode Breakdown:
00:00 – Opening and show introduction
01:02 – Meet guest Nicholas Talamantes and episode agenda
02:02 – Q2 earnings overview and market growth
05:15 – Spin-outs, mega-deals, and the venture ecosystem
08:39 – Key takeaways from a strong Q2
09:01 – Trade policy, tariffs, and AI regulation
14:25 – Trending stories: cardiology leads funding
16:57 – Acquisitions and diagnostics momentum
19:12 – Chronic disease management and IVD growth
22:01 – Strategic divestitures across medtech
24:44 – Robotics market snapshot and trends
28:52 – Olympus and Revival: robotic endoscopy push
31:21 – Fractal Health and Aqua Medical innovations
33:59 – Think Surgical and platform competition
35:28 – Biggest deals and raises in Q2
37:32 – Zimmer Biomet to acquire Monogram
41:56 – Favorite deals: Cardamon PFA and Nēros Medical
44:36 – Wrap-up and medtech resilience
45:14 – Compass platform and Europe plans
46:50 – Closing thanks and subscribe
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Subscribe to our LinkedIn Newsletter
https://www.stateofmedtechpodcast.com/
Follow The State of MedTech on
LinkedIn https://www.linkedin.com/company/thestateofmedtech
Instagram https://www.instagram.com/stateofmedtech/
TikTok https://www.tiktok.com/@stateofmedtech
X https://twitter.com/StateofMedTech
Facebook https://www.facebook.com/stateofmedtech/
Follow Omar M. Khateeb on
LinkedIn https://www.linkedin.com/in/okhateeb/
Instagram https://www.instagram.com/omar.m.khateeb/
TikTok https://www.tiktok.com/@omarkhateebofficial
X https://twitter.com/OmarMKhateeb
Facebook https://www.facebook.com/OmarMKhateeb/
#Medtech #HealthcareBusiness #EarningsSeason #MedicalDevices #Robotics